Navigation Links
Favrille Reports First Quarter 2008 Financial Results
Date:5/8/2008

>

(in thousands, except per share data)

Unaudited

Three Months ended

March 31,

2008 2007

Operating expenses:

Research and development $ 8,063 $ 7,997

Marketing, general and

administrative 2,556 2,912

Total operating expenses 10,619 10,909

Interest income 281 565

Interest expense (233) (187)

Change in valuation of

warrants 89 -

Total other income, net 137 378

Net loss $ (10,482) $ (10,531)

Net loss per share:

Basic and diluted $ (0.25) $ (0.34)

Weighted-average shares --

basic and diluted 41,182 30,690

FAVRILLE, INC.

(a development stage company)

STATEMENTS OF CASH FLOWS

(in thousands)

Unaudited

Three Months ended

March 31,

2008 2007

Operating activities:

Net loss $ (10,482) $ (10,531)

Adjustments to reconcile net loss to

net cash used in operating activities:

Depreciation and amortization 1,080 659

Stock-based compensation 1,117 1,054

Amortization of premiu
'/>"/>

SOURCE Favrille, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Favrille to Host Conference Call and Live Webcast to Discuss First Quarter 2008 Financial Results on May 8, 2008
2. Favrille Reports Fourth Quarter and Year End 2007 Financial Results
3. Favrille Announces $21.1 Million Registered Direct Offering
4. Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference
5. Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25, 2007
6. Favrille to Present at BIO InvestorForum
7. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
8. Favrille CEO to Present at Bear Stearns Healthcare Conference
9. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
10. Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
11. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-...ttheNASDAQOMXconferenceonTuesday,December1stat1:45...tenvialiveaudiobroadcastovertheInternetavailableat...Userscanclickthe"Webcast"icontoaccessthisfile. ,...ifeScienceandHighTechnologycompany.Itschemicalandb...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/-...ompanyfocusedondevelopingandcommercializingnovelpa...onno,PresidentandChiefExecutiveOfficer,isscheduled...erence,tobeheldDecember1-2,2009atTheNewYorkPalaceH...higlieri,ChiefFinancialOfficer,willbeavailabletore...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...euticals,Inc. (Nasdaq: CADX ), a biopharmaceutica...ommercializing proprietary product candidates prin...ounced that it completed its,previously announced ...llion shares of common stock at a price of $5.34 p...The proceeds from the offering will enable us to c...
...eutics, Inc., a,privately held ophthalmic-focused ... has entered into an exclusive licensing agreement...worldwide rights to develop and,market topical oph...oprietary anti- inflammatory agent norketotifen., ...220/CLW064LOGO ), "This agreement represents yet...
...ntures, specializing,in seed and early-stage inves...today announced the expansion of the firm,s invest..., PhD, as Venture Partner. 5AM Ventures,also annou...ociates, Kevin,M. Forrest, PhD, and R. Andrew McMi... have been with the 5AM team since early 2005. Car...
Other Biology Technology:Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering 2Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering 3Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 25AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 25AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 3
(Date:11/26/2009)...pressive antlers, red deer have been caught in the...lers are much more than decorative. They are letha... John Currey, from The University of York, UK, has...ne for over half a century and has become fascinat...a long-standing collaboration with Tomas Landete-C...
(Date:11/26/2009)...November 2009 What are the bare essentials of lif...ce a cell that can survive on its own? Can we desc...nd how an entire organism functions as a system? T...s in a partnership between the European Molecular ...and the Centre de Regulacio Genmica (CRG) in Barce...
(Date:11/25/2009)...ia don,t have easy lives. In addition to mammalian...atural enemies called bacteriophages, viruses that..., Still, bacteria and another class of microorga...environments such as deep-sea volcanic vents) mana... a built-in defense system that helps protect them...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Male seahorses like big mates 9136 1Male seahorses like big mates 9136 2Hormone clue to root growth 9134 1Hormone clue to root growth 9134 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 3
...veling migratory moths may hitch a ride on the win...urrent Biology, a Cell Press publication, confirm...us report also in Current Biology offered the fi...icated internal compass, sailing on favorable wind...in a matter of days. Now, the research team that b...
...I When it comes to embryo formation in the lowly ...eads to enhanced developmental precision, accordin...from Cincinnati Children,s Hospital Medical Center...roductive biology may seem insignificant, one day ...cause the study provides new information about how...
... Calif.-- The transportation of antibodies from a ...opment of that child,s nascent immune system. Thos...nta before birth or via breast milk after birth, h...nd may influence the later occurrence of autoimmun...ia Institute of Technology (Caltech) have revealed...
Other Biology News:Migratory moths may hitch their rides, but they're anything but drifters 2Scientists trace molecular origin of proportional development 2Scientists trace molecular origin of proportional development 3Caltech biologists spy on the secret inner life of a cell 2Caltech biologists spy on the secret inner life of a cell 3
...0 contains 400 unique human proteins on a 1x3 inch...a cross section of all cellular proteins, are arra...itional control proteins and a specific chip layou...NIchip protein microarrays are high-density protei...
...0 contains 400 unique human proteins on a 1x3 inch...all extracellular proteins (EP) according to Gene ...ate for high-quality results. Additional control p...validity and reproducibility., UNIchip protein mic...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...ed Reticulocyte Lysate Systems(a,b,c,d) offer rese...nslations: a single-tube, coupled transcription/tr...implify the process and reduce the time required t...bbit reticulocyte lysate translations (1) commonly...
Biology Products: